Literature DB >> 12620065

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.

V Craig Jordan1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12620065     DOI: 10.1021/jm020449y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  60 in total

1.  Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1).

Authors:  Edwin J Squirewell; Xiaoyan Qin; Michael W Duffel
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

2.  Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.

Authors:  V Craig Jordan; Ramona Curpan; Philipp Y Maximov
Journal:  J Natl Cancer Inst       Date:  2015-04-02       Impact factor: 13.506

3.  A two-stage differential hydrogen deuterium exchange method for the rapid characterization of protein/ligand interactions.

Authors:  Michael J Chalmers; Scott A Busby; Bruce D Pascal; Mark R Southern; Patrick R Griffin
Journal:  J Biomol Tech       Date:  2007-09

4.  Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.

Authors:  Milton T Sonoda; Leandro Martínez; Paul Webb; Munir S Skaf; Igor Polikarpov
Journal:  Mol Endocrinol       Date:  2008-04-10

Review 5.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

6.  Towards a rational spacer design for bivalent inhibition of estrogen receptor.

Authors:  Alexander Bujotzek; Min Shan; Rainer Haag; Marcus Weber
Journal:  J Comput Aided Mol Des       Date:  2011-02-18       Impact factor: 3.686

7.  Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy.

Authors:  V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-30       Impact factor: 13.506

8.  Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.

Authors:  Manghong Zhu; Chen Zhang; Jerome C Nwachukwu; Sathish Srinivasan; Valerie Cavett; Yangfan Zheng; Kathryn E Carlson; Chune Dong; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  Org Biomol Chem       Date:  2012-11-21       Impact factor: 3.876

9.  Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.

Authors:  Anna B Williams; Patrick T Weiser; Robert N Hanson; Jillian R Gunther; John A Katzenellenbogen
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

10.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.